Colorectal cancer: Review of signaling pathways and associated therapeutic strategies

被引:8
|
作者
Leiphrakpam, Premila D. [1 ,2 ]
Rajappa, Senthil J. [3 ]
Krishnan, Mridula [4 ]
Batra, Rishi [5 ]
Murthy, Shilpa S. [6 ]
Are, Chandrakanth [1 ,2 ,7 ]
机构
[1] Univ Nebraska Med Ctr, Coll Med, Grad Med Educ, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE USA
[3] Basavatarakam Indo Amer Canc Hosp, Med Oncol, Hyderabad, Telangana, India
[4] Univ Nebraska Med Ctr, Coll Med, Dept Internal Med, Div Oncol & Hematol, Omaha, NE USA
[5] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Gen Surg, Omaha, NE USA
[6] Mem Sloan Kettering Canc Ctr, Div Surg Oncol, Global Canc Dispar Initiat, New York, NY USA
[7] Univ Nebraska Med Ctr, Coll Med, Dept Surg, Div Surg Oncol, Omaha, NE 68198 USA
关键词
biomarkers; colorectal cancer; targeted therapy; RANDOMIZED PHASE-III; FOLFIRI PLUS BEVACIZUMAB; MOLECULAR SUBGROUP ANALYSES; FACTOR-BETA RECEPTOR; KRAS WILD-TYPE; OPEN-LABEL; 1ST-LINE TREATMENT; FOLFOXIRI PLUS; DOUBLE-BLIND; MAINTENANCE TREATMENT;
D O I
10.1002/jso.27295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor profiling and targeted therapy revolutionized the treatment strategies of metastatic colorectal cancer (mCRC) in the last decade. The heterogeneity of CRC tumors plays a critical role in the development of treatment resistance, which underscores the need to understand the molecular mechanism involved in CRC to develop novel targeted therapeutic strategies. This review provides an overview of the signaling pathways driving CRC, the existing targeted agents, their limitations, and future trends.
引用
收藏
页码:1277 / 1295
页数:19
相关论文
共 50 条
  • [2] Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer
    Habeeb, Mohammad
    You, Huay Woon
    Aher, Kiran Balasaheb
    Bhavar, Girija Balasaheb
    Khot, Vidyarani Sujitkumar
    Mishra, Shweta
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 84
  • [3] Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges
    Xin, Jiang
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 169 - 177
  • [4] Review Article Involvement of platelet signaling pathways in colorectal cancer and new therapeutic targets
    Bonfitto, Pedro Henrique Leite
    Rodrigues, Beatriz Alves Guerra
    Siqueira, Natalia Souza Nunes
    Genaro, Livia Moreira
    Rodrigues, Bruno Lima
    Oliveira, Priscilla de Sene Portel
    Martinez, Carlos Augusto Real
    Ayrizono, Maria de Lourdes Setsuko
    Leal, Raquel Franco
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (11): : 5133 - 5153
  • [5] Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)
    Ding, Ye
    Yu, Yong
    MOLECULAR MEDICINE REPORTS, 2025, 31 (04)
  • [6] Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies
    Yang, Zhengdong
    Wang, Xinyang
    Zhou, Huiying
    Jiang, Minghan
    Wang, Jinghui
    Sui, Bowen
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1389 - 1403
  • [7] Therapeutic strategies targeting Wnt/β-catenin signaling for colorectal cancer
    Ji, Yong
    Lv, Jian
    Sun, Di
    Huang, Yufeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2022, 49 (01)
  • [8] Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies
    Wang, Nannan
    Cao, Yuepeng
    Si, Chengshuai
    Shao, Peng
    Su, Guoqing
    Wang, Ke
    Bao, Jun
    Yang, Liu
    CANCERS, 2022, 14 (20)
  • [9] Response to Molecular Complexity of Colorectal Cancer: Pathways, Biomarkers, and Therapeutic Strategies
    Parepare, Agussalim
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1523 - 1524
  • [10] The Clinical Significance of MicroRNAs in Colorectal Cancer Signaling Pathways: A Review
    Michas, Athanasios
    Michas, Vasileios
    Anagnostou, Evangelos
    Galanopoulos, Michail
    Tolia, Maria
    Tsoukalas, Nikolaos
    GLOBAL MEDICAL GENETICS, 2023, 10 (04): : 315 - 323